Technology | June 26, 2015

Cheetah Medical Introduces Starling SV Noninvasive Hemodynamic Monitoring System

System predicts IV-fluids responsiveness similarly to esophageal Doppler and other invasive modalities

Cheetah Medical, Starling SV, hemodynamic monitoring system, noninvasive

June 26, 2015 - Cheetah Medical announced that it is now offering the U.S. Food and Drug Administration (FDA)-cleared and CE-marked Starling SV hemodynamic monitoring system. The noninvasive system provides data for real-time clinical decision-making and optimized patient outcomes across a hospital's continuum of care.

Dynamic IV fluid-assessment using the Starling SV and the benchmark Cheetah NICOM systems allow noninvasive, real-time knowledge of whether a patient will be helped or potentially harmed by additional IV fluids.

The expansion of Cheetah medical's product line comes on the heels of results in three major clinical trials (ProCESS, ProMISE, ARISE), as well as updated sepsis guidelines from several organizations - all of whom updated their guidance to include dynamic measures of fluid responsiveness for patients with severe sepsis or septic shock.

IV-fluid responsiveness is also a major component of Enhanced Recovery After Surgery (ERAS), which is showing improved clinical outcomes for surgical patients.

The Starling SV system has a sensitivity of 94 percent and specificity of 100 percent for predicting IV-fluids responsiveness in critical care situations. The system predicts IV-fluids responsiveness similarly to invasive esophageal Doppler and other invasive modalities. In addition to predicting fluid responsiveness, it is one of the few technologies that allows clinicians to directly monitor the change in cardiac stroke volume with therapy. Starling SV may assist in reducing hospital length of stay (LOS).

Other benefits of the system include:

  • Eliminates risk of infection and vascular damage associated with older, invasive technologies requiring arterial or central lines;
  • Independently validated against pulmonary artery catheter;
  • Accuracy not affected by vasopressors, inotropes, and shock states;
  • Nurse-driven;
  • Electronic medical record (EMR)-compatible, with the ability to establish a time-stamped patient record for documentation; and
  • Provides continuous information on cardiac index, cardiac output, stroke volume index, stroke volume, total peripheral resistance and other parameters.


For more information:

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Ohio State Investigating High-Tech Vest for At-Home Heart Failure Management
News | Heart Failure| June 28, 2017
Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest that measures fluid...
First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Northwell Health Partners With Peerbridge Health on Remote Patient Monitoring
News | Wearable Sensors| June 01, 2017
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of...
Overlay Init